Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Antineoplastic agents >  Antibiotics anticancer drugs >  Revumenib Citrate

Revumenib Citrate

Basic information Safety Supplier Related

Revumenib Citrate Basic information

Product Name:
Revumenib Citrate
Synonyms:
  • Revumenib Citrate
  • RMA-745
  • Revumenib citrate hydrate,2761046-45-9,,Pharmaceutical Chemicals
CAS:
2761046-45-9
MF:
C32H47FN6O4S.C6H8O7.H2O
MW:
840.96
Mol File:
2761046-45-9.mol
More
Less

Revumenib Citrate Chemical Properties

InChIKey
UBXFWTFPYATLBT-SGBGZXBGNA-N
SMILES
C([C@H]1CC[C@@H](CC1)NS(=O)(=O)CC)N1CCC2(CC1)CN(C1=NC=NC=C1OC1C=CC(=CC=1C(=O)N(CC)C(C)C)F)C2.C(O)(C(=O)O)(CC(=O)O)CC(=O)O.O |&1:1,4,r|
More
Less

Revumenib Citrate Usage And Synthesis

Description

Revumenib is an oral small molecule menin inhibitor that prevents the interaction between menin and aberrant KMT2A. It was approved by the FDA in November 2024 for the treatment of leukemia with KMT2A aberrations. Revumenib Citrate is a common salt of Revumenib.

Revumenib CitrateSupplier

JINAN SHENGQI PHARMACEUTICAL CO., LTD
Tel
0531-88892685 18660160628
Email
15069007290@163.com
Aktin Chemicals, Inc.
Tel
028-85159085
Email
info@aktinchem.com
NANJING WEDO PHARMATECH CO.,LTD.
Tel
15189836218 15189836218;
Email
wedo-chem@huawe.com
Hubei Rhema Reference Materials Technology Co., Ltd.
Tel
15787879035 15787875101
Email
ydw9035@rmastandards.com
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
Tel
+86-18600796368
Email
sales@sjar-tech.com